Pancreatic Cancer Research

ResearcherChung-Ang UniversityNo recent work listed

In Gyu Hwang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7461-0333; OpenAlex author ID A5011928803. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). Co-author DOI 10.1016/j.ejca.2021.08.002↗
  2. Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study. Co-author DOI 10.1186/s40880-018-0304-1↗
  3. A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer. Co-author DOI 10.1007/s10637-012-9792-z↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jung Hun Kang · 3 shared papers, 2012–2021 · strength 0.21
  2. Jung Hoon Kim · 2 shared papers, 2018–2021 · strength 0.18
  3. Hyun Woo Lee · 2 shared papers, 2018–2021 · strength 0.18
  4. Se‐Il Go · 2 shared papers, 2012–2021 · strength 0.14
  5. Dae Young Zang · 1 shared paper, 2021 · strength 0.11
  6. Woo Kyun Bae · 1 shared paper, 2021 · strength 0.11
  7. Jun Ho Ji · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.